Beijing, China

Shaolin Huang

This inventor holds 1 USPTO granted patent. Top assignee: Beijing Chenguang Tongchuang Pharmaceutical Research Institute Co., Ltd.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shaolin Huang. Retrieved from https://idiyas.com/inventor/shaolin-huang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shaolin Huang

Introduction

Shaolin Huang is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on prodrug compounds. His research focuses on improving the solubility and pharmacokinetic profiles of existing medications.

Latest Patents

Shaolin Huang holds a patent for a prodrug compound of levosimendan, which includes a preparation method and its uses. This invention addresses the limitations of levosimendan, such as its poor water solubility. The prodrug compound is designed to enhance the drug's effectiveness and has promising prospects for development in the pharmaceutical industry.

Career Highlights

Huang is affiliated with the Beijing Chenguang Tongchuang Pharmaceutical Research Institute Co., Ltd. His work at this institute has allowed him to focus on innovative drug development and contribute to advancements in medical treatments.

Collaborations

Some of his notable coworkers include Changbin Guo and Wei Li, who have collaborated with him on various research projects. Their combined expertise has furthered the development of new pharmaceutical solutions.

Conclusion

Shaolin Huang's contributions to the field of pharmaceuticals through his innovative patent work exemplify the importance of research and development in medicine. His efforts continue to pave the way for advancements in drug efficacy and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…